Skip to main content
Figure 4 | Irish Veterinary Journal

Figure 4

From: Voluntary acceptance and consumption of two oral ciclosporin formulations in dogs: two randomised, controlled studies

Figure 4

Evolution of product voluntary acceptance throughout the study 2 period. This chart presents the voluntary acceptance of the tested products on each study day. * Statistical difference between the products (p < 0.05). Cyclavance® was significantly more often easily accepted than Atopica® throughout the study period without any influence of study days (p < 0.0001).

Back to article page